Your Web Site
Among the earnings stories for Wednesday, July 23, from AP Financial News: Top stories: NEW YORK (AP)--New York Times Co.'s second-quarter earnings fell 82 percent from a year ago, when it saw a one-time gain from the sale of a unit, but print advertising continued to shrink and pulled down operating income, the publisher said Wednesday. Other stories: LONDON (AP)--GlaxoSmithKline PLC, the world's second-largest drug maker, posted a 3 percent drop in second-quarter profit on Wednesday, after strong competition from generic drugs outweighed asset sales and the cost-saving effects of job cuts. GRAND RAPIDS, Mich. (AP)--Household appliance maker Whirlpool Corp. said Wednesday its profit fell 27 percent in the second quarter because of higher material and oil-related costs, and lower U.S. demand. PHILADELPHIA (AP)--Regional bank... [read full story]
|
FULL COVERAGE
|
|
LONDON (AFP) - British pharmaceutical giant GlaxoSmithKline said on Wednesday that second-quarter net profits slipped owing to competition from generic drugmakers and sliding sales of diabetes drug Avandia. Net profit declined...
Competition from generic drugs weighed on GlaxoSmithKline's bottom line in the second quarter, the pharmaceutical company said Wednesday. Glaxo (NYSE: GSK) said it earned 1.29 billion pounds ($2.56 billion) in the quarter....
LONDON (AFP) - GSK's new chief executive Andrew Witty used his maiden results to unveil a major strategy overhaul aimed at diversifying the group's operations as it seeks higher growth and to reduce risk. Net profit declined by...
GlaxoSmithKline PLC, the world's second largest drug maker, posted a 3 percent fall in second quarter net profit on Wednesday after strong competition from generic drugs outweighed asset sales and the cost-saving effects of job...
GlaxoSmithKline PLC, the world's second-largest drug maker, posted a 3 percent drop in second-quarter profit on Wednesday, after strong competition from generic drugs outweighed asset sales and the cost-saving effects of job cuts.
GlaxoSmithKline PLC, the world's second-largest drug maker, posted a 3 percent drop in second-quarter profit on Wednesday, after strong competition from generic drugs outweighed asset sales and the cost-saving effects of job cuts.
LONDON (AFP) - GSK's new chief executive Andrew Witty used his maiden results to unveil a major strategy overhaul aimed at diversifying the group's operations as it seeks higher growth and to reduce risk. Net profit declined by...
LONDON (AFP) - British pharmaceutical giant GlaxoSmithKline said on Wednesday that second-quarter net profits slipped owing to competition from generic drugmakers and sliding sales of diabetes drug Avandia. Net profit declined...
New York Times Co.'s second-quarter earnings fell 82 percent from a year ago, when it saw a one-time gain from the sale of a unit, but print advertising continued to shrink and pulled down operating income, the publisher said...
Glaxo Plans to Diversify; Profit Rises |Published: July 23, 2008 7:53 AM Active Discussions on SmartMoney By Elena Berton Of DOW JONES NEWSWIRES LONDON -(Dow Jones)- GlaxoSmithKline PLC (GSK) Wednesday unveiled a major strategy...

